Company search
Overview
Performance
Portfolio
ESG
Dividends
Charges
Gearing
Research
Announcements
Management
Documents
Invest
Data as at: 19/05/2026
In
Objective
To achieve long term capital growth by investing primarily in listed companies throughout the world.
AIC sector
Management group
Launch date
10/07/1998
October
Domicile
United Kingdom
Fund manager
Douglas Brodie, Svetlana Viteva, Luke Ward
Dividend frequency
Annually
Wind-up provisions
The Company has an unlimited life.
| Market Cap (m) | Total assets (m) | Price (last close) | NAV | Discount / premium (%) | Gearing (%) | Dividend yield (%) | Dividend dates | Ongoing charge (%) |
|---|---|---|---|---|---|---|---|---|
| 871.63 | 927.60 | 252.00 | 245.80 | 2.52 | 3 | 0.00 | Oct | 0.85 (31/10/2025) |
Scroll
Dividends
Dividends declared in last 12 months
There have been no dividends in the last 12 months.
Performance (%)
| Return type | 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|---|
| Edinburgh Worldwide | Share price total return | 51.9 | 67.2 | -20.4 | 196.4 |
| Global Smaller Companies AIC sector | Share price total return | 29.3 | 50.1 | 13.5 | 190.3 |
Scroll
Share structure
Number of shares
345,884,292
59,869,403
Traded volumes (number of shares)
| Yesterday | 1 month | 1 year | 5 years | |
|---|---|---|---|---|
| Total | 871,428 | 31,042,494 | 294,117,179 | 1,213,329,325 |
| Average | N/A | 1,478,210 | 1,162,520 | 962,196 |
Scroll
Traded values (m)
| Yesterday | 1 month | 1 year | 5 years | |
|---|---|---|---|---|
| Total | 2.20 | 74.76 | 619.43 | 2,381.15 |
| Average | N/A | 3.56 | 2.45 | 1.89 |
Scroll
Trading details
| ISIN | Ticker | Traded currency | Stock exchange |
|---|---|---|---|
| GB00BHSRZC82 | EWI | GBX | London Stock Exchange - MAIN Chi-x Europe Limited London Stock Exchange |
Scroll
Top holdings
Data as at : 28/02/2026
| Investment | % of total assets |
|---|---|
| Space Exploration Technologies Corp Series N Pref. | 16.2 |
| Alnylam Pharmaceuticals Inc | 4.8 |
| Psiquantum Series C Pref. | 3.9 |
| Axon Enterprise Inc | 3.0 |
| AeroVironment Inc | 2.6 |
| Psiquantum Series D Pref. | 2.5 |
| Oxford Nanopore Technologies PLC | 2.4 |
| Twist Bioscience Corp | 2.1 |
| Aehr Test Systems | 2.1 |
| Aspeed Technology Inc | 2.0 |
Data provided by Morningstar.
Company documents provided by FE fundinfo.
